SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-19-270376
Filing Date
2019-10-21
Accepted
2019-10-21 06:11:39
Documents
4

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 13240
2 GRAPHIC g637051snap014.jpg GRAPHIC 10765
3 GRAPHIC g637051snap015.jpg GRAPHIC 6209
4 GRAPHIC g637051snap016.jpg GRAPHIC 3240
  Complete submission text file 0001193125-19-270376.txt   42429
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)